Bone marrow affected by multiple myeloma, a disease against which PVR inhibition can increase the efficacy of immunotherapy. (IMAGE)

Josep Carreras Leukaemia Research Institute

Bone marrow affected by multiple myeloma, a disease against which PVR inhibition can increase the efficacy of immunotherapy.

Caption

Bone marrow affected by multiple myeloma, a disease against which PVR inhibition can increase the efficacy of immunotherapy.

Credit

Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute

Usage Restrictions

Published at Leukemia

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.